KURA

Kura Oncology, Inc.

Pharmaceutical Preparations · SIC 2834CIK 1422143Held by 4 tracked managersEDGAR filings ↗10-K/10-Q ↗

SHARE:X LINKEDIN EMAIL

4 managers · Q2 2026 13F

13F bookWeight

Suvretta Capital Management

Suvretta Capital ManagementPosition history →

2.0%

—

$94.1M

$4.76B13F book · 2026-06-30

Royce & Associates

Royce & AssociatesPosition history →

0.05%

NEW

$6.7M

$12.42B13F book · 2026-06-30

Renaissance Technologies

Renaissance TechnologiesPosition history →

0.03%

+5.1%

$18.3M

$72.62B13F book · 2026-06-30

Alps Advisors

Alps AdvisorsPosition history →

<0.01%

+25.3%

$1.0M

$21.33B13F book · 2026-06-30

Weight = position value ÷ the manager's total 13F long-equity value in the same filing — one definition for every row. “1st obs.” marks a position with no earlier stored 13F to compare against — it is not shown as a purchase.